Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 4;23(4):158.
doi: 10.3390/md23040158.

Marine-Derived Bioactive Compounds: A Promising Strategy for Ameliorating Skeletal Muscle Dysfunction in COPD

Meiling Jiang  1 , Peijun Li  2 , Xiaoyu Han  1 , Linhong Jiang  2 , Lihua Han  1 , Qinglan He  1 , Chen Yang  1 , Zhichao Sun  1 , Yingqi Wang  2 , Yuanyuan Cao  1 , Xiaodan Liu  2 , Weibing Wu  1
Affiliations
Review

Marine-Derived Bioactive Compounds: A Promising Strategy for Ameliorating Skeletal Muscle Dysfunction in COPD

Meiling Jiang et al. Mar Drugs. .

Abstract

Chronic obstructive pulmonary disease (COPD) is frequently accompanied by skeletal muscle dysfunction, a critical and severe extrapulmonary complication. This dysfunction contributes to reduced exercise capacity, increased frequency of acute exacerbations, and elevated mortality, serving as an independent risk factor for poor prognosis in COPD patients. Owing to the unique physicochemical conditions of the marine environment, marine-derived bioactive compounds exhibit potent anti-inflammatory and antioxidant properties, demonstrating therapeutic potential for ameliorating COPD skeletal muscle dysfunction. This review summarizes marine-derived bioactive compounds with promising efficacy against skeletal muscle dysfunction in COPD, including polysaccharides, lipids, polyphenols, peptides, and carotenoids. The discussed compounds have shown bioactivities in promoting skeletal muscle health and suppressing muscle atrophy, thereby providing potential strategies for the prevention and treatment of COPD skeletal muscle dysfunction. These findings may expand the therapeutic strategies for managing COPD skeletal muscle dysfunction.

Keywords: COPD; carotenoids; lipids; marine-derived bioactive compounds; peptides; polyphenols; polysaccharides; skeletal muscle dysfunction.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 2
Figure 2
Chemical structures of polysaccharides with potentially therapeutic effects on COPD skeletal muscle dysfunction: (a) Fucoidan, (b) Chitosan.
Figure 3
Figure 3
Chemical structures of lipids with potentially therapeutic effects on COPD skeletal muscle dysfunction: (a) Docosahexaenoic acid, (b) Eicosapentaenoic acid, (c) Docosapentaenoic acid, (d) Fucosterol.
Figure 4
Figure 4
Chemical structures of polyphenols with potentially therapeutic effects to COPD skeletal muscle dysfunction: (a) Diphlorethohydroxycarmalol, (b) Dieckol, (c) 2,7″-phloroglucinol-6,6′-bieckol.
Figure 5
Figure 5
Chemical structures of carotenoids with potentially therapeutic effects on COPD skeletal muscle dysfunction: (a) Astaxanthin, (b) Fucoxanthin, (c) β-carotene, (d) β-cryptoxanthin, (e) Lutein, (f) Zeaxanthin.
Figure 1
Figure 1
The primary pathogenesis of skeletal muscle dysfunction in COPD.
Figure 6
Figure 6
Bioactivities of marine-derived bioactive compounds in relation to COPD skeletal muscle dysfunction.
See this image and copyright information in PMC

References

    1. Celli B., Fabbri L., Criner G., Martinez F.J., Mannino D., Vogelmeier C., Montes D.O.M., Papi A., Sin D.D., Han M.K., et al. Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision. Am. J. Respir. Crit. Care Med. 2022;206:1317–1325. - PMC - PubMed
    1. Chen S., Kuhn M., Prettner K., Yu F., Yang T., Bärnighausen T., Bloom D.E., Wang C. The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020–50: A health-augmented macroeconomic modelling study. Lancet Glob. Health. 2023;11:e1183–e1193. - PMC - PubMed
    1. Wang C., Xu J., Yang L., Xu Y., Zhang X., Bai C., Kang J., Ran P., Shen H., Wen F., et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): A national cross-sectional study. Lancet. 2018;391:1706–1717. - PubMed
    1. Jiang M., Li P., Wang Y., Cao Y., Han X., Jiang L., Liu X., Wu W. Role of Nrf2 and exercise in alleviating COPD-induced skeletal muscle dysfunction. Ther. Adv. Respir. Dis. 2023;17:1611179335. doi: 10.1177/17534666231208633. - DOI - PMC - PubMed
    1. Gea J., Orozco-Levi M., Barreiro E., Ferrer A., Broquetas J. Structural and functional changes in the skeletal muscles of COPD patients: The “compartments” theory. Monaldi Arch. Chest Dis. 2001;56:214–224. - PubMed

MeSH terms

LinkOut - more resources